| NDC Code | 0186-0520-60 |
|---|
| Package Description | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0186-0520-60) |
|---|
| Product NDC | 0186-0520 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Vimovo |
|---|
| Non-Proprietary Name | Naproxen And Esomeprazole Magnesium |
|---|
| Dosage Form | TABLET, DELAYED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20100706 |
|---|
| End Marketing Date | 20170331 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA022511 |
|---|
| Manufacturer | AstraZeneca Pharmaceuticals LP |
|---|
| Substance Name | NAPROXEN; ESOMEPRAZOLE MAGNESIUM |
|---|
| Strength | 500; 20 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
|---|